Edition:
United Kingdom

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

23.30USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$23.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
90,103
52-wk High
$35.52
52-wk Low
$16.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.518
FY 2017 Dec '17 0.00 -0.362
Sep '17 0.00 -0.384
Jun '17 0.00 -0.224
Mar '17 0.00 -0.220
FY 2016 Dec '16 0.00 -0.163
Sep '16 0.00 -0.414
Jun '16 0.00 -0.419
Mar '16 0.00 -0.210
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 2.53 4.00 0.50 --
Quarter Ending Dec-18 4 7.26 10.79 5.00 --
Year Ending Dec-18 4 9.64 11.29 8.00 --
Year Ending Dec-19 4 74.00 81.00 59.30 --
Earnings (per share)
Quarter Ending Sep-18 4 -0.58 -0.45 -0.78 --
Quarter Ending Dec-18 4 -0.50 -0.35 -0.68 --
Year Ending Dec-18 4 -2.24 -1.93 -2.79 --
Year Ending Dec-19 4 -0.96 -0.68 -1.24 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.48 32.76
P/E High - Last 5 Yrs. -- 298.85 45.44
P/E Low - Last 5 Yrs. -- 91.59 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 112.69 5.73
Price to Book (MRQ) -- 14.09 5.45
Price to Tangible Book (MRQ) -- 14.67 7.05
Price to Cash Flow (TTM) -- 72.72 23.29
% Owned Institutions 23.71 14.42 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.51
Dividend Yield - 5 Year Avg -- 0.27 1.52
Dividend 5 Year Growth Rate -- 1.70 5.22
Payout Ratio(TTM) -- 16.38 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 408.74 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.05 5.64
Sales - 5 Yr. Growth Rate -- 32.09 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.59 29.06 20.60
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.56 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.05 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.22
Current Ratio (MRQ) 0.83 5.50 3.03
LT Debt to Equity (MRQ) -- 25.57 12.39
Total Debt to Equity (MRQ) -- 27.28 16.72
Interest Coverage (TTM) -- -101.33 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.25 54.37
Gross Margin - 5 Yr. Avg. -- 50.67 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -588.18 10.81
Operating Margin (TTM) -- -734.89 4.57
Operating Margin - 5 Yr. Avg. -- -609.81 6.23
Pre-Tax Margin (TTM) -- -708.96 5.43
Pre-Tax Margin - 5 Yr. Avg. -- -613.30 6.67
Net Profit Margin (TTM) -- -710.36 1.73
Net Profit Margin - 5 Yr. Avg. -- -616.33 2.94
Effective Tax Rate (TTM) -- 23.27 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.59 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,066,163 860,414,722
Net Income/Employee (TTM) -3,672,143 3,124,085 101,211,891
Receivable Turnover (TTM) -- 20.78 5.87
Inventory Turnover (TTM) -- 2.48 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.33 11.14
Return on Assets - 5 Yr. Avg. -- 3.75 12.40
Return on Investment (TTM) -- 2.29 14.61
Return on Investment - 5 Yr. Avg. -- 2.93 16.14
Return on Equity (TTM) -- 3.86 16.34
Return on Equity - 5 Yr. Avg. -- 4.40 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Dova Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.20%
# of Holders: 93
Total Shares Held: 13,023,886
3 Mo. Net Change: 346,522
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 4
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.